Access cutting-edge clear cell renal cell carcinoma treatment through this clinical trial at a research site in Middletown. Study-provided care at no cost to qualified participants.
Access clear cell renal cell carcinoma specialists in Middletown at no cost
This study follows strict safety protocols and ethical guidelines
All study-related clear cell renal cell carcinoma treatment provided free
The researchers are doing this study to find out whether it is practical (feasible) to give cemiplimab and fianlimab before a nephrectomy and whether it causes any delays with surgery in people with kidney cancer. The researchers will also look at whether cemiplimab and fianlimab given before a nephrectomy is a safe and effective treatment approach and if there is a change in the size of the tumor following immunotherapy prior to planned surgery.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this clear cell renal cell carcinoma clinical trial in Middletown, NJ
If you're searching for clear cell renal cell carcinoma treatment options in Middletown, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Middletown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced clear cell renal cell carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.